AtriCure (ATRC) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $28.79 +1.34%
EPS Growth %: +92.3%
Financial Fact:
Loss from operations: -6.29M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: +92.3%
Financial Fact:
Loss from operations: -6.29M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.30), $0.01 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $73.2 million versus the consensus estimate of $72.39 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance
- Schwab's May activity shows margin loans nearly double
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
